Streetbeat News

TELIF

Telescope Innovations Corp

Open

0.28

Mkt cap

15M

Volume

6.5K

High

0.29

P/E Ratio

-14.50

52-wk high

0.56

Low

0.24

Div yield

N/A

52-wk low

0.20

Telescope Innovations Corporation is set to present at the Virtual Life Science Investor Forum on March 13th, inviting individual and institutional investors, advisors, and analysts to attend online.

Portfolio Pulse from

March 11, 2025 | 1:00 pm

Telescope Innovations Corp. has commenced trading on the Frankfurt Stock Exchange, expanding its visibility and accessibility to European investors.

Portfolio Pulse from

February 19, 2025 | 8:30 am

Telescope Innovations Corp.'s Founder and CTO, Professor Jason Hein, has been awarded the 2025 R.U. Lemieux Award, highlighting the company's leadership in advanced technologies for the pharmaceutical and chemical industries.

Portfolio Pulse from

February 10, 2025 | 1:15 pm

Telescope Innovations Corp. reported its financial results for the first fiscal quarter of 2025, with revenues of $1.2 million and an adjusted EBITA loss of $103K. The revenue was driven by strong sales and market adoption of its product, DirectInject-LC™.

Portfolio Pulse from

January 27, 2025 | 11:30 pm

Telescope Innovations Corp. reported increased revenues of $4.4 million for the fiscal year ending August 31, 2024, despite an Adjusted EBITDA loss of $152K. The growth supports major research and commercialization projects in intelligent automation and advanced chemical manufacturing.

Portfolio Pulse from

December 23, 2024 | 11:15 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.